- Home
- MTAL vs CRON Comparison
MTAL vs CRON Comparison
Compare MTAL & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTAL
- CRON
- Stock Information
- Founded
- MTAL 2021
- CRON N/A
- Country
- MTAL Jersey
- CRON Canada
- Employees
- MTAL N/A
- CRON N/A
- Industry
- MTAL Blank Checks
- CRON Medicinal Chemicals and Botanical Products
- Sector
- MTAL Finance
- CRON Health Care
- Exchange
- MTAL Nasdaq
- CRON Nasdaq
- Market Cap
- MTAL 1.0B
- CRON 809.4M
- IPO Year
- MTAL 2021
- CRON N/A
- Fundamental
- Price
- MTAL $12.23
- CRON $2.67
- Analyst Decision
- MTAL Hold
- CRON
- Analyst Count
- MTAL 4
- CRON 0
- Target Price
- MTAL $12.08
- CRON N/A
- AVG Volume (30 Days)
- MTAL 1.4M
- CRON 2.7M
- Earning Date
- MTAL 11-09-2025
- CRON 11-11-2025
- Dividend Yield
- MTAL N/A
- CRON N/A
- EPS Growth
- MTAL N/A
- CRON N/A
- EPS
- MTAL N/A
- CRON 0.05
- Revenue
- MTAL $321,804,000.00
- CRON $130,282,000.00
- Revenue This Year
- MTAL $17.15
- CRON $19.67
- Revenue Next Year
- MTAL $24.95
- CRON $30.56
- P/E Ratio
- MTAL N/A
- CRON $55.65
- Revenue Growth
- MTAL N/A
- CRON 28.01
- 52 Week Low
- MTAL $7.69
- CRON $1.60
- 52 Week High
- MTAL $14.31
- CRON $2.77
- Technical
- Relative Strength Index (RSI)
- MTAL 67.03
- CRON 63.95
- Support Level
- MTAL $12.12
- CRON $2.50
- Resistance Level
- MTAL $12.22
- CRON $2.63
- Average True Range (ATR)
- MTAL 0.03
- CRON 0.09
- MACD
- MTAL 0.00
- CRON -0.01
- Stochastic Oscillator
- MTAL 100.00
- CRON 84.00
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.